New drug shows promise against stomach bug in early trial
NCT ID NCT07249463
First seen Dec 08, 2025 · Last updated May 04, 2026 · Updated 19 times
Summary
This study tests a new drug called EDI048 in healthy adults who are intentionally infected with the parasite that causes cryptosporidiosis, a diarrheal disease. The goal is to see if the drug can reduce the severity and duration of diarrhea compared to a placebo. The results will help decide if the drug should be tested in children, who are most affected by this illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRYPTOSPORIDIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Pharmaron Inc
RECRUITINGBaltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.